J&J | Built to matter: oncology startup strategies to stand out in a crowded market

J&J | Built to matter: oncology startup strategies to stand out in a crowded market

This Johnson & Johnson Innovation event brings together investors, pharma leaders, biotech executives and advisors to explore the strategic choices that can make oncology startups more investable, partnerable and attractive to potential acquirers.

Gain practical perspectives on the strategic decisions that can shape an oncology venture’s path forward. The programme will explore investor and buyer expectations, clinical development considerations and the factors that influence successful partnerships.

Register for the event here.

Testimonials

testimonial

A lot of fruitful discussions with experienced peers. Very helpful sessions.

Sara Matt-Leubner

University of Innsbruck, Austria

testimonial

The software course has provided invaluable information as our TTO expands to take on software cases.

Tom Withnell

University of Vienna, Austria

testimonial

ASTP brought the right structure and terminology to my knowledge of technology licensing.

René Widmer

ETH Transfer, Switzerland

testimonial

Technology transfer is ever changing and a key piece for the competitiveness of your institution, this course is an excellent tool to prepare yourself for that challenge.

Ricardo Castro

Centre for research in agricultural Genomics, Spain

testimonial

This course offers an opportunity to meet likeminded people, share tips and tricks, and dive into different approaches to help you set up and improve KTO processes.

Brechtje Vreenegoor

Radboud University, Netherlands